- Home
- TARA vs THTX Comparison
TARA vs THTX Comparison
Compare TARA & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- THTX
- Stock Information
- Founded
- TARA N/A
- THTX 1993
- Country
- TARA United States
- THTX Canada
- Employees
- TARA N/A
- THTX N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- TARA Health Care
- THTX Health Care
- Exchange
- TARA Nasdaq
- THTX Nasdaq
- Market Cap
- TARA 126.5M
- THTX 144.8M
- IPO Year
- TARA N/A
- THTX N/A
- Fundamental
- Price
- TARA $3.33
- THTX $3.17
- Analyst Decision
- TARA Strong Buy
- THTX Hold
- Analyst Count
- TARA 7
- THTX 1
- Target Price
- TARA $20.67
- THTX N/A
- AVG Volume (30 Days)
- TARA 452.5K
- THTX 1.1M
- Earning Date
- TARA 08-05-2025
- THTX 07-09-2025
- Dividend Yield
- TARA N/A
- THTX N/A
- EPS Growth
- TARA N/A
- THTX N/A
- EPS
- TARA N/A
- THTX N/A
- Revenue
- TARA N/A
- THTX $84,378,000.00
- Revenue This Year
- TARA N/A
- THTX N/A
- Revenue Next Year
- TARA N/A
- THTX $15.13
- P/E Ratio
- TARA N/A
- THTX N/A
- Revenue Growth
- TARA N/A
- THTX 2.19
- 52 Week Low
- TARA $1.60
- THTX $1.12
- 52 Week High
- TARA $10.48
- THTX $3.20
- Technical
- Relative Strength Index (RSI)
- TARA 55.94
- THTX 72.50
- Support Level
- TARA $3.25
- THTX $2.28
- Resistance Level
- TARA $3.23
- THTX $3.20
- Average True Range (ATR)
- TARA 0.17
- THTX 0.02
- MACD
- TARA 0.04
- THTX -0.00
- Stochastic Oscillator
- TARA 81.25
- THTX 100.00
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.